AU1979283A - Nitroglycerine solution - Google Patents

Nitroglycerine solution

Info

Publication number
AU1979283A
AU1979283A AU19792/83A AU1979283A AU1979283A AU 1979283 A AU1979283 A AU 1979283A AU 19792/83 A AU19792/83 A AU 19792/83A AU 1979283 A AU1979283 A AU 1979283A AU 1979283 A AU1979283 A AU 1979283A
Authority
AU
Australia
Prior art keywords
solution
nitroglycerine
nitroglycerine solution
glycerine
nitro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU19792/83A
Inventor
Kurt Burghart
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
G Pohl Boskamp GmbH and Co Chemisch Pharmazeutische Fabrik
Original Assignee
Pohl Boskamp G Co Chemisch Pharmazeutische Fabrik GmbH
G Pohl Boskamp GmbH and Co Chemisch Pharmazeutische Fabrik
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6175236&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU1979283(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pohl Boskamp G Co Chemisch Pharmazeutische Fabrik GmbH, G Pohl Boskamp GmbH and Co Chemisch Pharmazeutische Fabrik filed Critical Pohl Boskamp G Co Chemisch Pharmazeutische Fabrik GmbH
Publication of AU1979283A publication Critical patent/AU1979283A/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

1. Aqueous nitro-glycerine solution, which is free from solubilizers and organic solvents, characterised in that it contains from 0.8 to 1.1 mg and preferably 1 mg of nitro-glycerine/ml of solution.
AU19792/83A 1982-10-08 1983-09-30 Nitroglycerine solution Abandoned AU1979283A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19823237284 DE3237284A1 (en) 1982-10-08 1982-10-08 SOLVENT-FREE, AQUEOUS NITROGLYCERIN SOLUTION
DE3237284 1982-10-08

Publications (1)

Publication Number Publication Date
AU1979283A true AU1979283A (en) 1984-04-12

Family

ID=6175236

Family Applications (1)

Application Number Title Priority Date Filing Date
AU19792/83A Abandoned AU1979283A (en) 1982-10-08 1983-09-30 Nitroglycerine solution

Country Status (4)

Country Link
EP (1) EP0108248B2 (en)
AT (1) ATE39416T1 (en)
AU (1) AU1979283A (en)
DE (1) DE3237284A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4007705C1 (en) * 1990-03-10 1991-09-26 G. Pohl-Boskamp Gmbh & Co. Chemisch-Pharmazeutische Fabrik, 2214 Hohenlockstedt, De
EP2878310B1 (en) 2013-11-29 2017-01-11 G. Pohl-Boskamp GmbH & Co. KG Sprayable aqueous composition comprising glyceryl trinitrate

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2301664C3 (en) * 1973-01-13 1979-07-12 Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz Oral medicine containing nitroglycerin
JPS599539B2 (en) * 1979-11-13 1984-03-03 日本化薬株式会社 Nitroglycerin aqueous solution and its manufacturing method
DE3109783C2 (en) * 1981-03-13 1987-04-02 Schwarz GmbH, 4019 Monheim Process for the preparation of an ethanol-free nitroglycerin solution with a concentration of about 1 mg nitroglycerin/ml

Also Published As

Publication number Publication date
EP0108248B1 (en) 1988-12-28
EP0108248A3 (en) 1984-09-05
ATE39416T1 (en) 1989-01-15
DE3237284C2 (en) 1990-05-31
DE3237284A1 (en) 1984-04-12
EP0108248B2 (en) 1999-09-15
EP0108248A2 (en) 1984-05-16

Similar Documents

Publication Publication Date Title
HK1001834A1 (en) Stable ascorbic acid compositions
AU1261583A (en) N-glycosylated carboxamide derivatives
DE3382637D1 (en) A LIQUID SOLUBLE SUBSTANCE CONTAINING AQUEOUS LIQUID.
KR890009962A (en) Manimicin derivatives, preparation methods and uses thereof
KR880008801A (en) Solution for parenteral administration
AU1979283A (en) Nitroglycerine solution
ZA872664B (en) Six-membered heterocyclic derivatives of n'-substituted-n,n'-diacylhydrazines
KR830005168A (en) Method for preparing 5- (dihydroxyphenoxy) tetrazole
GR73158B (en)
FI884960A (en) ANVAENDNING AV 2-PYRIMIDINYL-1-PIPERAZINE DERIVATIVES.
FR2526418B1 (en) PROPULSIVE COMPOSITION CONTAINING NITROCELLULOSE, NITROGLYCERIN, COPPER BENZOATE AND LEAD OR DERIVATIVES THEREOF, ESPECIALLY FOR ROCKETS
BG90414A (en) 2-AZABICYCLO (2,2,1)-HEPT-5-EN-2-ACETIC ACID AND ITS DERIVATIVES, METHOD OF PREPARATION AND THEIR APPLICATION
AU538268B2 (en) Animal feeds
FR2378518A1 (en) NEW MEDICINES BASED ON TETRAHYDRODIBENZOPYRANE DERIVATIVES
DE3368199D1 (en) Mixture comprising a central analgesic and vitamin b12, or one of its analogs, as active principles
KR880012226A (en) External agent
AU4610689A (en) Pyridine-3-peroxycarboxylic acid monopersulfate
AU5026979A (en) Recovery of mg from sludge
FI930292A (en) FOERFARANDE FOER ATT AVLAEGSNA SYRA UR NITROS SUBSTITUTES AROMATER MED HJAELP AV SMAELT NITRATSALT
KR920002497A (en) Sterol compound
AU553275B2 (en) Stable oxytetracyclin solutions
BG30922A3 (en) Operating station, especially for hanging chain conveyors
ZA943338B (en) Preparation of symmetrical or unsymmetrical disubstituted n-cyanodithiominocarbonates
FR2359117A1 (en) 4-NITRO-2-TRIFLUOROMETHYLDIPHENYLAMINES
KR890001582A (en) Countercurrent